BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 30293724)

  • 1. APOE ɛ4, rs405509, and rs440446 promoter and intron-1 polymorphisms and dementia risk in a cohort of elderly Finns-Helsinki Birth Cohort Study.
    Rantalainen V; Lahti J; Kajantie E; Tienari P; Eriksson JG; Raikkonen K
    Neurobiol Aging; 2019 Jan; 73():230.e5-230.e8. PubMed ID: 30293724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE and aging-related cognitive change in a longitudinal cohort of men.
    Rantalainen V; Lahti J; Henriksson M; Kajantie E; Tienari P; Eriksson JG; Raikkonen K
    Neurobiol Aging; 2016 Aug; 44():151-158. PubMed ID: 27318143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The algorithm for Alzheimer risk assessment based on APOE promoter polymorphisms.
    Limon-Sztencel A; Lipska-Ziętkiewicz BS; Chmara M; Wasag B; Bidzan L; Godlewska BR; Limon J
    Alzheimers Res Ther; 2016 May; 8(1):19. PubMed ID: 27193889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The TT allele of rs405509 synergizes with APOE ε4 in the impairment of cognition and its underlying default mode network in non-demented elderly.
    Ma C; Zhang Y; Li X; Chen Y; Zhang J; Liu Z; Chen K; Zhang Z
    Curr Alzheimer Res; 2016; 13(6):708-17. PubMed ID: 26825091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.
    Tilvis RS; Strandberg TE; Juva K
    J Am Geriatr Soc; 1998 Jun; 46(6):712-5. PubMed ID: 9625186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics.
    Melgarejo JD; Aguirre-Acevedo DC; Gaona C; Chavez CA; Calmón GE; Silva ER; de Erausquin GA; Gil M; Mena LJ; Terwilliger JD; Arboleda H; Scarmeas N; Lee JH; Maestre GE
    J Alzheimers Dis; 2020; 77(2):569-579. PubMed ID: 32675415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish brain power initiative.
    Wang HX; Gustafson DR; Kivipelto M; Pedersen NL; Skoog I; Windblad B; Fratiglioni L
    Neurobiol Aging; 2012 May; 33(5):1007.e1-7. PubMed ID: 22056199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease.
    Bratosiewicz-Wasik J; Liberski PP; Peplonska B; Styczynska M; Smolen-Dzirba J; Cycon M; Wasik TJ
    Neurosci Lett; 2018 Sep; 684():86-90. PubMed ID: 29990559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.
    Helisalmi S; Hiltunen M; Valonen P; Mannermaa A; Koivisto AM; Lehtovirta M; Ryynänen M; Soininen H
    J Neurol; 1999 Sep; 246(9):821-4. PubMed ID: 10525981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can elderly apolipoprotein E ε4 carriers remain free from dementia?
    Ferrari C; Xu WL; Wang HX; Winblad B; Sorbi S; Qiu C; Fratiglioni L
    Neurobiol Aging; 2013 Jan; 34(1):13-21. PubMed ID: 22503000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
    Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
    Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
    Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Cheng YC; Huang YC; Liu HC
    Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
    Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
    Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of lipid metabolism gene SAR1 homolog B and the risk of Alzheimer's disease and vascular dementia.
    Chen JH; Hsieh CJ; Huang YL; Chen YC; Chen TF; Sun Y; Wen LL; Yip PK; Chu YM
    J Formos Med Assoc; 2016 Jan; 115(1):38-44. PubMed ID: 25703997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.